FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Baxter Healthcare DIANEAL Low Calcium Recall

DIANEAL Low Calcium (2

Baxter Healthcare Corporation · Deerfield, IL

Risk level
Class II
Reported by FDA
Sep 6, 2023
Recall ID
D-1140-2023
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled DIANEAL Low Calcium starting Aug 11, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1140-2023 on Sep 6, 2023. Reason: Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

Product description

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution 1.5% Dextrose, packaged in a) 2000 mL AMBU-FLEX II Container bag, Product Code L5B4825, NDC 0941-0409-06; b) 5000 mL AMBU-FLEX II Container bag, Product Code L5B4826, NDC 0941-0409-07; and c) 6000 mL AMBU-FLEX II Container bag, Product Code L5B9770, NDC 0941-0409-01, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.

Lot numbers, UPCs & expiration codes

a) Lots Y403948, Exp 30-Sep-2024; Lot Y406277, Exp 31-Oct-2024. b) Lot 408790, Exp 30-Nov-2024 and c) Lots Y403740, Y403740A, Exp 30-Sep-2024; Lots Y405638, Y405805, Y407304, Y407304A Exp 31-Oct-2024; Lots Y407717, Y407717A, Y408554, Exp 30-Nov-2024; Lot Y420075, Exp 30-Apr-2025

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1140-2023
Classification
Class II
Status
Terminated
Recall initiated
Aug 11, 2023
FDA report date
Sep 6, 2023
Quantity
a) 44,520; b) 60,762; c) 483,912
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corporation

Original FDA data

Every field from FDA enforcement report D-1140-2023, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Terminated
Country
United States
Event ID
92931
Address
1 Baxter Pkwy
Code information
a) Lots Y403948, Exp 30-Sep-2024; Lot Y406277, Exp 31-Oct-2024. b) Lot 408790, Exp 30-Nov-2024 and c) Lots Y403740, Y403740A, Exp 30-Sep-2024; Lots Y405638, Y405805, Y407304, Y407304A Exp 31-Oct-2024; Lots Y407717, Y407717A, Y408554, Exp 30-Nov-2024; Lot Y420075, Exp 30-Apr-2025
Postal code
60015-4625
Report date
Sep 6, 2023
Product type
Drugs
Recall number
D-1140-2023
Classification
Class II
Recalling firm
Baxter Healthcare Corporation
Product quantity
a) 44,520; b) 60,762; c) 483,912
Termination date
Jul 16, 2024
Reason for recall
Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.
Voluntary / mandated
Voluntary: Firm initiated
Product description
DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution 1.5% Dextrose, packaged in a) 2000 mL AMBU-FLEX II Container bag, Product Code L5B4825, NDC 0941-0409-06; b) 5000 mL AMBU-FLEX II Container bag, Product Code L5B4826, NDC 0941-0409-07; and c) 6000 mL AMBU-FLEX II Container bag, Product Code L5B9770, NDC 0941-0409-01, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.
Distribution pattern
Nationwide in the USA
Recall initiation date
Aug 11, 2023
Initial firm notification
Letter
Center classification date
Aug 29, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1140-2023, published Sep 6, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls